The first BioAtla trade was made in Q1 2021.
Since then Ken Griffin bought shares 26 more times and sold shares on 26 occasions. The investor completely sold their stake between Q2 2026 and Q2 2026.
Avg closing price
Price range
Sold -8.71k shares
Q2 2026
Avg closing price
$4.23
Price range
$3.31
-
$6.73
New holding (+8.71k shares)
Q1 2026
Avg closing price
$11.70
Price range
$7.06
-
$26.71
Sold -5.48k shares
Q4 2025
Avg closing price
$39.21
Price range
$28.39
-
$61.00
New holding (+5.48k shares)
Q3 2025
Avg closing price
$23.09
Price range
$16.50
-
$38.75
Sold -1.54k shares
Q1 2025
Avg closing price
$21.39
Price range
$15.25
-
$33.90
Increased shares by 38500.0% (+1.54k shares)
Q4 2024
Avg closing price
$83.92
Price range
$29.50
-
$118.50
Sold 99.9% shares (-3.7k shares)
Q3 2024
Avg closing price
$83.85
Price range
$58.50
-
$102.50
Increased shares by 155.2% (+2.25k shares)
Q2 2024
Avg closing price
$118.98
Price range
$68.50
-
$196.00
Sold 0.6% shares (-9 shares)
Q1 2024
Avg closing price
$124.24
Price range
$94.00
-
$173.00
Sold 36.2% shares (-829 shares)
Q4 2023
Avg closing price
$86.68
Price range
$63.50
-
$159.00
Sold 13.4% shares (-354 shares)
Q3 2023
Avg closing price
$127.45
Price range
$85.00
-
$153.50
Sold 74.2% shares (-7.6k shares)
Q2 2023
Avg closing price
$171.99
Price range
$141.50
-
$193.50
Increased shares by 670.8% (+8.92k shares)
Q1 2023
Avg closing price
$180.11
Price range
$115.00
-
$412.50
Sold 17.3% shares (-279 shares)
Q4 2022
Avg closing price
$414.87
Price range
$314.50
-
$550.50
Sold 55.0% shares (-1.97k shares)
Q3 2022
Avg closing price
$327.35
Price range
$147.00
-
$593.50
Increased shares by 77.1% (+1.56k shares)
Q2 2022
Avg closing price
$159.15
Price range
$106.50
-
$269.00
Increased shares by 138.5% (+1.17k shares)
Q1 2022